ZA89833B - 5-substituted ornithine derivatives - Google Patents

5-substituted ornithine derivatives

Info

Publication number
ZA89833B
ZA89833B ZA89833A ZA89833A ZA89833B ZA 89833 B ZA89833 B ZA 89833B ZA 89833 A ZA89833 A ZA 89833A ZA 89833 A ZA89833 A ZA 89833A ZA 89833 B ZA89833 B ZA 89833B
Authority
ZA
South Africa
Prior art keywords
ornithine derivatives
substituted ornithine
substituted
derivatives
ornithine
Prior art date
Application number
ZA89833A
Other languages
English (en)
Inventor
Fritz E Gerhart
E Gerhart Fritz
Nikolaus J Seiler
J Seiler Nikolaus
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA89833B publication Critical patent/ZA89833B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
ZA89833A 1988-02-05 1989-02-02 5-substituted ornithine derivatives ZA89833B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400275A EP0326766B1 (de) 1988-02-05 1988-02-05 5-Substituierte Ornithin-Derivate

Publications (1)

Publication Number Publication Date
ZA89833B true ZA89833B (en) 1989-10-25

Family

ID=8200349

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89833A ZA89833B (en) 1988-02-05 1989-02-02 5-substituted ornithine derivatives

Country Status (22)

Country Link
US (1) US4902719A (de)
EP (1) EP0326766B1 (de)
JP (1) JP2816431B2 (de)
KR (1) KR0150634B1 (de)
CN (1) CN1027891C (de)
AR (1) AR244657A1 (de)
AT (1) ATE77367T1 (de)
AU (1) AU612229B2 (de)
CA (1) CA1311767C (de)
DE (1) DE3872213T2 (de)
DK (1) DK172113B1 (de)
ES (1) ES2041815T3 (de)
FI (1) FI90530C (de)
GR (1) GR3005551T3 (de)
HU (1) HU204770B (de)
IE (1) IE63162B1 (de)
IL (1) IL89145A (de)
NO (1) NO176242C (de)
NZ (1) NZ227783A (de)
PH (1) PH26422A (de)
PT (1) PT89637B (de)
ZA (1) ZA89833B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132363T2 (de) * 1990-04-26 2001-03-29 Procter & Gamble Chelat-zubereitung, die alpha-diamin-verbindungen enthalten
EP0609630A1 (de) * 1993-02-05 1994-08-10 Merrell Dow Pharmaceuticals Inc. Verwendung von Ornithin-Aminotransferase-Inhibitoren zur Herstellung eines Arzneimittels zur Behandlung der alzheimerschen Krankheit
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
GB9617822D0 (en) * 1996-08-27 1996-10-09 Lilly Industries Ltd Pharmaceutical compounds
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US6566330B1 (en) 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
US6911544B2 (en) * 2002-10-23 2005-06-28 Pfizer Inc. Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
WO2015060149A1 (ja) 2013-10-21 2015-04-30 富士電機株式会社 制御系設計支援装置、制御系設計支援プログラム、制御系設計支援方法、操作変化量算出装置および制御装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1091661A (en) * 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
CA1174603A (en) * 1980-06-16 1984-09-18 Albert Sjoerdsma Method of inhibiting the growth of protozoa
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids

Also Published As

Publication number Publication date
IL89145A (en) 1993-08-18
EP0326766B1 (de) 1992-06-17
IE890356L (en) 1989-08-05
DK51589A (da) 1989-08-06
DE3872213T2 (de) 1993-01-28
IE63162B1 (en) 1995-03-22
NO176242B (no) 1994-11-21
KR890012942A (ko) 1989-09-20
FI90530C (fi) 1994-02-25
FI890477A0 (fi) 1989-02-01
FI890477A (fi) 1989-08-06
ES2041815T3 (es) 1993-12-01
CN1027891C (zh) 1995-03-15
FI90530B (fi) 1993-11-15
DK172113B1 (da) 1997-11-10
CN1037142A (zh) 1989-11-15
PT89637B (pt) 1994-02-28
ATE77367T1 (de) 1992-07-15
AR244657A1 (es) 1993-11-30
AU2951589A (en) 1989-08-10
NZ227783A (en) 1990-12-21
GR3005551T3 (de) 1993-06-07
PT89637A (pt) 1989-10-04
JPH021435A (ja) 1990-01-05
IL89145A0 (en) 1989-09-10
PH26422A (en) 1992-07-15
NO890455L (no) 1989-08-07
DK51589D0 (da) 1989-02-03
DE3872213D1 (de) 1992-07-23
NO890455D0 (no) 1989-02-03
NO176242C (no) 1995-03-01
CA1311767C (en) 1992-12-22
EP0326766A1 (de) 1989-08-09
JP2816431B2 (ja) 1998-10-27
KR0150634B1 (ko) 1998-10-15
HUT49320A (en) 1989-09-28
US4902719A (en) 1990-02-20
HU204770B (en) 1992-02-28
AU612229B2 (en) 1991-07-04

Similar Documents

Publication Publication Date Title
YU222289A (en) Hinuklidin derivatives
GB8905443D0 (en) Dihalogrnobenzene derivatives
EP0377789A3 (en) Interlining
GB2222828B (en) Butynylamine derivatives
PH27571A (en) Capsiacin derivatives
EG19385A (en) N-phenylpyrazol -4-yl-ether derivatives
IL89230A0 (en) Acylphenol derivatives
ZA89860B (en) Pyranobenzoxadiazole derivatives
PH27235A (en) Benzopyranol derivatives
IL89145A0 (en) 5-substituted ornithine derivatives
ZA892723B (en) Phosphonoalkylpurine derivatives
GB2222829B (en) Benzylidenecyclanone derivatives
ZA899424B (en) Novel benzopyranylpyrrolinone derivatives
YU200589A (en) Derivatives 3-acyl-2-oxyndol-1-carboxamida
ZA892148B (en) Novel delta4-androstene derivatives
EP0355353A3 (en) Cycloalkylthiazole derivatives
ZA898604B (en) Pyranylethyl-naphthalene derivatives
IL90695A0 (en) Substituted azacyclohexyl derivatives
ZA893169B (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA899582B (en) Benzohydroxymic derivatives
ZA893942B (en) Aminophenol derivatives
FI103406B1 (fi) 3-piperatsinyylibentsatsolijohdannainen
IE882251L (en) Benzothiazone derivatives
IE883569L (en) Cycloocteneimine derivatives
GB8822387D0 (en) Halocyclohexanone derivatives